Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic features

A new human leukaemic cell line (M‐O7) with the phenotypic characteristics of CFU‐mega is described. Its cells are positive for T200 leucocyte common antigen (LCA) and negative with MAbs recognizing T and B cells and mature myelomonocytic antigens. In contrast, they react with MAbs recognizing antigenic determinants common to multilineage (CD13, CD33, CD34) and to bipotent erythromegakaryoblastic (CD36, H25) haemopoietic precursors, and with MAbs specific for platelet glycoproteins (CD41w, CD42w). A small proportion (10%) of the cells were large and multinucleated, and on electron microscopy examination showed peripheral splitting of platelet‐like cytoplasm particles. When transferred to a serum‐free Iscove modified Dulbecco's medium supplemented with human insulin and transferrin, M‐O7 cells stop proliferating. Of the haemopoietic growth factors tested for their ability to restore the proliferative activity of this quiescent population, only rH IL‐3 proved effective. Moreover, it also increased the cloning efficiency in methylcellulose more than any other CSFs. The M‐O7 cell line may provide a valuable tool for the biological assay of IL‐3, and a model for biochemical studies of the megakaryocytic lineage.

[1]  E. Dessypris,et al.  Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro , 1987, British journal of haematology.

[2]  R. Ross,et al.  Constitutive and inducible secretion of platelet-derived growth factor analogs by human leukemic cell lines coexpressing erythroid and megakaryocytic markers. , 1987, The Journal of clinical investigation.

[3]  B. Clarkson,et al.  Expression of two natural killer cell antigens, H-25 and H-366, by human immature myeloid cells and by erythroid and granulocytic/monocytic colony-forming units. , 1987, Blood.

[4]  J. Trepel,et al.  Phorbol ester induces c-sis gene transcription in stem cell line K-562 , 1986, Molecular and cellular biology.

[5]  F. Malavasi,et al.  3' c-myc rearrangement in a human leukemic T-cell line. , 1986, Cancer research.

[6]  D. Catovsky,et al.  Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[7]  J. Griffin,et al.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia. , 1985, The Journal of clinical investigation.

[8]  P. Nowell,et al.  A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Mcgarrity Mycoplasma infection of cell cultures: thymidine incorporation of culture supernatants as a screening test. , 1984, Journal of immunology.

[10]  M. Fackler,et al.  Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. , 1984, Journal of immunology.

[11]  W. Vainchenker,et al.  Expression of platelet membrane glycoproteins and alpha‐granule proteins by a human erythroleukemia cell line (HEL). , 1984, The EMBO journal.

[12]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[13]  T. Braciale,et al.  Mycoplasma infection of cell cultures: thymidine incorporation of culture supernatants as a screening test. , 1984, Journal of immunology.

[14]  I. Bernstein,et al.  Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies , 1983 .

[15]  G. Johnson,et al.  The production of committed hemopoietic colony-forming cells from multipotential precursor cells in vitro. , 1982, Blood.

[16]  R. Hoffman,et al.  Constitutive expression of platelet glycoproteins by the human leukemia cell line K562 , 1982 .

[17]  T. Papayannopoulou,et al.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. , 1982, Science.

[18]  T. Waldmann,et al.  Clustered arrangement of immunoglobulin λ constant region genes in man , 1981, Nature.

[19]  A. Axelrad,et al.  Chromosome marker evidence for the bipotentiality of BFU-E. , 1980, Blood.

[20]  S. Collins,et al.  Replacement of serum by insulin and transferrin supports growth and differentiation of the human promyelocytic cell line, HL-60. , 1980, Experimental cell research.

[21]  R. Humphries,et al.  Characterization of a primitive erythropoietic progenitor found in mouse marrow before and after several weeks in culture. , 1979, Blood.

[22]  T. Chen,et al.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. , 1977, Experimental cell research.

[23]  A. Axelrad,et al.  Induction of megakaryocyte colonies with platelet formation in vitro , 1976, Nature.

[24]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[25]  M. Seabright A rapid banding technique for human chromosomes. , 1971, Lancet.

[26]  M. Greaves,et al.  Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. , 1985, Leukemia research.

[27]  T. Koike Megakaryoblastic leukemia: the characterization and identification of megakaryoblasts. , 1984, Blood.

[28]  J. Ritz,et al.  Expression of MY7 antigen on myeloid precursor cells. , 1983, International journal of cell cloning.

[29]  I. Bernstein,et al.  Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies. , 1983, Blood.

[30]  R. Hoffman,et al.  Constitutive expression of platelet glycoproteins by the human leukemia cell line K562. , 1982, Blood.

[31]  D. Golde,et al.  Human leukemia cell line K562 responds to erythroid-potentiating activity. , 1982, Blood.

[32]  F. Reyes,et al.  Acute Leukemia : Identification by the Ultrastructural Demonstration of Platelet Peroxidase , 2022 .

[33]  C. Lozzio,et al.  Properties of the K562 cell line derived from a patient with chronic myeloid leukemia. , 1977, International journal of cancer.